Clinical Trials Market
Clinical Trials Market
The global clinical trials market size is calculated at USD 54.39 billion in 2024 and is expected to be worth USD 94.68 billion by 2034, expanding at a CAGR of 5.7% from 2024 to 2034.
Report ID: 10019
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 54.39 Bn
Forecast Year,
USD USD 94.68 Bn
CAGR, 2025 -
5.7%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Clinical Trials Market Size Analysis
Clinical Trials Market Size By Phase 2024 to 2034 (USD )
| Phase | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1 | 8.16 | 8.65 | 9.21 | 9.71 | 10.38 | 10.99 | 11.57 | 12.31 | 13.00 | 13.84 | 14.51 |
| Phase 2 | 13.60 | 14.25 | 14.97 | 15.82 | 16.73 | 17.71 | 18.73 | 19.75 | 20.91 | 21.97 | 23.33 |
| Phase 3 | 24.48 | 25.89 | 27.34 | 28.97 | 30.50 | 32.27 | 34.12 | 36.07 | 38.25 | 40.54 | 42.89 |
| Phase 4 | 8.16 | 8.70 | 9.25 | 9.73 | 10.28 | 10.79 | 11.42 | 12.05 | 12.59 | 13.23 | 13.96 |
Clinical Trials Market Size By Study Design 2024 to 2034 (USD )
| Study Design | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Observational Study | 10.88 | 11.47 | 12.16 | 12.82 | 13.43 | 14.07 | 14.78 | 15.57 | 16.33 | 17.22 | 18.15 |
| Interventional Study | 40.79 | 43.26 | 45.63 | 48.32 | 51.16 | 54.04 | 57.05 | 60.48 | 64.19 | 67.88 | 71.76 |
| Expanded Access Study | 2.72 | 2.76 | 2.98 | 3.09 | 3.31 | 3.65 | 4.02 | 4.12 | 4.23 | 4.47 | 4.78 |
Clinical Trials Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Autoimmune/Inflammation | 10.88 | 11.37 | 12.13 | 12.91 | 13.60 | 14.38 | 15.21 | 15.95 | 16.93 | 17.82 | 18.83 |
| Pain Management | 6.53 | 6.82 | 7.26 | 7.64 | 8.18 | 8.69 | 9.24 | 9.67 | 10.31 | 11.00 | 11.79 |
| CNS Condition | 9.79 | 10.33 | 10.85 | 11.34 | 11.92 | 12.74 | 13.62 | 14.48 | 15.05 | 15.68 | 16.59 |
| Diabetes | 5.44 | 5.86 | 6.22 | 6.70 | 6.87 | 7.18 | 7.48 | 8.01 | 8.50 | 9.16 | 9.69 |
| Obesity | 4.35 | 4.57 | 4.71 | 5.06 | 5.48 | 5.75 | 5.99 | 6.29 | 6.65 | 7.16 | 7.59 |
| Cardiovascular | 8.16 | 8.70 | 9.12 | 9.52 | 10.13 | 10.69 | 11.33 | 11.99 | 12.64 | 13.10 | 13.89 |
| Others | 9.25 | 9.84 | 10.48 | 11.07 | 11.71 | 12.33 | 12.98 | 13.79 | 14.67 | 15.65 | 16.30 |
Clinical Trials Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 24.48 | 25.87 | 27.30 | 28.86 | 30.45 | 32.30 | 34.18 | 36.12 | 38.13 | 40.21 | 42.52 |
| Europe | 13.60 | 14.45 | 15.27 | 16.18 | 17.20 | 18.17 | 19.23 | 20.26 | 21.33 | 22.39 | 23.73 |
| Asia-Pacific | 10.88 | 11.57 | 12.09 | 12.82 | 13.57 | 14.32 | 15.24 | 15.96 | 17.03 | 17.88 | 18.92 |
| Latin America | 2.72 | 2.86 | 3.16 | 3.32 | 3.39 | 3.58 | 3.72 | 4.01 | 4.10 | 4.51 | 4.62 |
| Middle East & Africa | 2.72 | 2.74 | 2.95 | 3.05 | 3.28 | 3.40 | 3.49 | 3.82 | 4.15 | 4.59 | 4.89 |
Clinical Trials Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
